Follow
Jude A Oben MD(Oxon), PhD, FRCP, FRCPE, AGAF, FAASLD
Jude A Oben MD(Oxon), PhD, FRCP, FRCPE, AGAF, FAASLD
Consultant, Guy's and St Thomas' Hospital London; Associate Professor, King's College London.
Verified email at kcl.ac.uk - Homepage
Title
Cited by
Cited by
Year
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
10292019
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
NNI Philip N Newsome, Kristine Buchholtz, Kenneth Cusi , Martin Linder ...
New England Journal of Medicine 384 (doi: 10.1056/NEJMoa2028395), 1113-1124, 2021
10062021
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study
A Dennis, M Wamil, J Alberts, J Oben, DJ Cuthbertson, D Wootton, ...
BMJ open 11 (3), e048391, 2021
5012021
Advancing the global public health agenda for NAFLD: a consensus statement
JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ...
Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022
4132022
Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice
JA Oben, A Mouralidarane, AM Samuelsson, PJ Matthews, ML Morgan, ...
Journal of hepatology 52 (6), 913-920, 2010
3392010
Hepatic fibrogenesis requires sympathetic neurotransmitters
JA Oben, T Roskams, S Yang, H Lin, N Sinelli, M Torbenson, U Smedh, ...
Gut 53 (3), 438-445, 2004
2782004
Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis
A Hirose, M Ono, T Saibara, Y Nozaki, K Masuda, A Yoshioka, ...
Hepatology 45 (6), 1375-1381, 2007
2742007
Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1 (7–36) amide, on fatty acid synthesis in explants of rat adipose tissue
J Oben, L Morgan, J Fletcher, V Marks
Journal of Endocrinology 130 (2), 267-272, 1991
2371991
A guide to non-alcoholic fatty liver disease in childhood and adolescence
JL Temple, P Cordero, J Li, V Nguyen, JA Oben
International journal of molecular sciences 17 (6), 947, 2016
2322016
Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice
A Mouralidarane, J Soeda, C Visconti‐Pugmire, AM Samuelsson, ...
Hepatology 58 (1), 128-138, 2013
1612013
Norepinephrine regulates hepatic innate immune system in leptin‐deficient mice with nonalcoholic steatohepatitis
Z Li, JA Oben, S Yang, H Lin, EA Stafford, MJ Soloski, SA Thomas, ...
Hepatology 40 (2), 434-441, 2004
1362004
Norepinephrine and neuropeptide Y promote proliferation and collagen gene expression of hepatic myofibroblastic stellate cells
JA Oben, S Yang, H Lin, M Ono, AM Diehl
Biochemical and biophysical research communications 302 (4), 685-690, 2003
1302003
Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury
JA Oben, T Roskams, S Yang, H Lin, N Sinelli, Z Li, M Torbenson, ...
Hepatology 38 (3), 664-673, 2003
1272003
Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis
PN Newsome, ME Allison, PA Andrews, G Auzinger, CP Day, ...
Gut 61 (4), 484-500, 2012
1152012
Sympathetic nervous system regulation of liver repair
JA Oben, AM Diehl
The Anatomical Record Part A: Discoveries in Molecular, Cellular, and …, 2004
1052004
Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice
JA Oben, T Roskams, S Yang, H Lin, N Sinelli, Z Li, M Torbenson, ...
Biochemical and biophysical research communications 308 (2), 284-292, 2003
1032003
Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells
B Sigala, C McKee, J Soeda, V Pazienza, M Morgan, CI Lin, C Selden, ...
PloS one 8 (9), e72928, 2013
952013
Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings
C Panebianco, JA Oben, M Vinciguerra, V Pazienza
Clinical and experimental medicine 17, 269-280, 2017
912017
Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease
T Asanuma, M Ono, K Kubota, A Hirose, Y Hayashi, T Saibara, O Inanami, ...
Gut 59 (2), 258-266, 2010
822010
Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells
J Soeda, M Morgan, C McKee, A Mouralidarane, CI Lin, T Roskams, ...
Biochemical and biophysical research communications 417 (1), 17-22, 2012
812012
The system can't perform the operation now. Try again later.
Articles 1–20